SCHEMBL8910736

SCHEMBL8910736

C[N+](C)(C)CC(OP(=O)([O-])O)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LAP3 P28838 2/20 0.37
MAPT P10636 3/20 0.34
SLC22A16 Q86VW1 1/20 0.34
TSHR P16473 2/20 0.33
CHRM2 P08172 2/20 0.33
CHRM4 P08173 2/20 0.33
CHRM1 P11229 2/20 0.33
TBXA2R P21731 1/20 0.33
LMNA P02545 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
FOLH1 Q04609 1/20 0.33
CYP1A2 P05177 1/20 0.33
HRH1 P35367 1/20 0.33
CPT2 P23786 1/20 0.32
CPT1A P50416 1/20 0.32
CHRM5 P08912 1/20 0.32
CHRM3 P20309 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1003887 0.80 SLC22A16 (0.31) SLC22A16TSHRCHRM2CHRM4CHRM1
SCHEMBL338774 0.80 MEN1 (0.36) MAPTSLC22A16TSHRCHRM2CHRM4
SCHEMBL30673761 0.75 MAPT (0.44) MAPTTSHRLMNAMEN1KMT2A
SCHEMBL30673768 0.75 MAPT (0.44) MAPTTSHRLMNAMEN1KMT2A
SCHEMBL5190821 0.75 MAPT (0.44) MAPTTSHRLMNAMEN1KMT2A
SCHEMBL31173704 0.75 MAPT (0.44) MAPTTSHRLMNAMEN1KMT2A
SCHEMBL8911564 0.75 SLC22A16 (0.38) MAPTSLC22A16TSHRCHRM2CHRM4
SCHEMBL737340 0.73 CPT2 (0.38) LAP3MAPTSLC22A16TSHRCHRM2
SCHEMBL2553127 0.73 SLC22A16 (0.32) MAPTSLC22A16TSHRCHRM2CHRM4
SCHEMBL11347712 0.73 SLC22A16 (0.32) MAPTSLC22A16TSHRCHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5591882-A Process for preparing organophosphates useful for increasing the ocular haemo- and biocompatibility of synthetic polymers BIOCOMPATIBLES LIMITED (GB) 1997-01-07 US disclosed
EP-0518959-B1 METHOD OF IMPROVING THE OCULAR HAEMO AND BIOCOMPATIBILITY OF SYNTHETIC POLYMERS BIOCOMPATIBLES LTD (GB) 1996-11-20 EP disclosed
US-5422402-A Surface treatment (of an acrylic, polypropylene, polyethylene, polyurethane, polysaccharide, or cellulosic material) with quaternary ammonium phosphate inner salt having a reactive functional group; contact lenses; blood filtration BIOCOMPATIBLES LIMITED (GB) 1995-06-06 US disclosed
EP-0518959-A1 METHOD OF IMPROVING THE OCULAR HAEMO AND BIOCOMPATIBILITY OF SYNTHETIC POLYMERS. BIOCOMPATIBLES LTD (GB) 1992-12-23 EP disclosed
WO-1991013639-A1 METHOD OF IMPROVING THE OCULAR HAEMO AND BIOCOMPATIBILITY OF SYNTHETIC POLYMERS BIOCOMPATIBLES LIMITED (GB) 1991-09-19 WO disclosed